Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Obesity Studies

Adipocyte-Specific Deletion of Manganese Superoxide Dismutase Protects From Diet-Induced Obesity Through Increased Mitochondrial Uncoupling and Biogenesis

  1. Yong Hwan Han1,
  2. Márcio Buffolo1,
  3. Karla Maria Pires1,
  4. Shaobo Pei1,
  5. Philipp E. Scherer2,3 and
  6. Sihem Boudina1⇑
  1. 1Department of Nutrition and Integrative Physiology; Division of Endocrinology, Metabolism and Diabetes; and Program in Molecular Medicine, University of Utah School of Medicine, Salt Lake City, UT
  2. 2Touchstone Diabetes Center, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX
  3. 3Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX
  1. Corresponding author: Sihem Boudina, sihem.boudina{at}hmbg.utah.edu.
Diabetes 2016 Sep; 65(9): 2639-2651. https://doi.org/10.2337/db16-0283
PreviousNext
  • Article
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    MnSOD deletion in adipocytes increased superoxide generation but did not enhance lipid peroxidation. Representative Western blots and the corresponding densitometry of MnSOD protein expression normalized by SDHA expression in isolated adipocytes from iWAT (A) and eWAT (B). MnSOD protein expression normalized GAPDH protein expression in whole interscapular BAT homogenates (C). D: Superoxide levels in isolated adipocytes from iWAT of WT or AdSod2 KO mice fed an NCD or HFD for 21 weeks. E: Representative Western blot of 4-HNE and GAPDH protein expression in iWAT. F: Densitometry of 4-HNE normalized by GAPDH. G: Relative mRNA expression of major antioxidant enzymes in iWAT. n = 3–6 mice per group. Data are mean ± SEM. *P < 0.05, **P < 0.005 vs. WT under the same feeding condition; #P < 0.05, ##P < 0.005 vs. NCD within the same genotype.

  • Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2

    MnSOD deficiency in adipocytes reduced diet-induced weight gain and adiposity. Body weights (A), weight gain (B), iWAT weight/body weight (BW) × 103 (C), eWAT weight/BW × 103 (D), BAT weight/BW × 103 (E) in WT or AdSod2 KO mice maintained on NCD or HFD for 21 weeks. F: Representative images of iWAT and eWAT sections stained with hematoxylin and eosin. G and H: Distribution of adipocyte diameter in iWAT and eWAT, respectively. I and J: Adipocyte number per area in iWAT and eWAT, respectively. n = 12–18 mice per group for A–E. Ten images per animal were used to quantify adipocyte diameter and number for five to six mice per group. Scale bar = 40 μm. Data are mean ± SEM. *P < 0.05, **P < 0.005 vs. WT under the same feeding condition; #P < 0.05, ##P < 0.005 vs. NCD within the same genotype.

  • Figure 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3

    Deletion of MnSOD in adipocytes increased metabolic rate and EE when mice are maintained on an HFD. VO2 (A) and VCO2 (B) at night averaged over a 72-h period. Calculated RER (C) and EE (D). Food intake (E) and ambulatory activity (F) in WT and AdSod2 KO mice fed NCD or HFD for 12 weeks. n = 6–9 mice per group. Data are mean ± SEM. *P < 0.05 vs. WT under the same feeding condition; ##P < 0.005 vs. NCD within the same genotype.

  • Figure 4
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4

    Increased metabolic rate and FA utilization in HFD-fed AdSod2 KO mice at thermoneutrality. WT and AdSod2 KO mice fed NCD or HFD for 8–9 weeks were housed in metabolic cages for 72 h, and their VO2, VCO2, and RER were recorded at 23°C, 15°C, and 30°C. A–C: Changes in VO2, VCO2, and RER, respectively, over 72 h. D–F: Average night data for VO2, VCO2, and RER, respectively. n = 4 mice per group. Data are mean ± SEM. *P < 0.05, **P < 0.005 vs. WT under the same feeding condition; ##P < 0.005 vs. NCD within the same genotype.

  • Figure 5
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5

    MnSOD deficiency triggered an HFD-dependent increase in FA oxidation, mitochondrial respiration, and mitochondrial biogenesis. WT and AdSod2 KO mice were maintained on an HFD for 21 weeks. A: Palmitate oxidation in iWAT, eWAT, BAT, and hindlimb muscle. B: Fold change in mRNA expression of FA oxidation and mitochondrial biogenesis genes in iWAT. C and D: OCR and mtDNA/nuclear DNA ratios in iWAT. E and F: Electron micrographs and quantification of mitochondrial density in iWAT. n = 8–9 mice per group in A, and n = 6 mice per group in B. OCR, mtDNA, and mitochondrial density were quantified in three different sections of iWAT from three to four mice per group. Data are mean ± SEM. *P < 0.05, **P < 0.005 vs. WT. cpm, counts per minute.

  • Figure 6
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6

    Lack of MnSOD increased superoxide generation, uncoupled respiration, and enhanced mitochondrial content in cultured adipocytes. APs were isolated from iWAT of WT or AdSod2 KO mice fed NCD or HFD for 12 weeks and differentiated into adipocytes. A: Representative Western blots of MnSOD and tubulin protein expression before differentiation (day 0) and 6 and 12 days postdifferentiation. Representative images of Oil Red O staining of neutral lipids (B) and the corresponding quantification at 6 days postdifferentiation (C). Superoxide levels (D), OCRs (E), and mtDNA/nuclear DNA ratios (F) at 12 days postdifferentiation. G: Fold change in Ucp1 and Cidea mRNA in iWAT. n = 3 independent experiments (each included five to six mice per group). Scale bar = 40 μm in B. Data are mean ± SEM. *P < 0.05 vs. WT under the same feeding condition; #P < 0.05 vs. NCD within the same genotype. A.U., arbitrary units; DIFF, differentiated; UND, undifferentiated.

  • Figure 7
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7

    AdSod2 KO mice are protected from diet-induced hepatic steatosis, adipose inflammation, and glucose and insulin intolerance. A and B: Representative images of liver sections stained with Oil Red O and liver triglyceride content in WT and AdSod2 KO mice fed NCD and HFD for 21 weeks. C and D: Macrophage (F4/80) staining and quantification in eWAT. E: Fold change in mRNA expression of pro- and anti-inflammatory genes in eWAT. F–H: Body weights, GTTs, and areas under the curve (AUCs) for GTT in WT and AdSod2 KO mice fed NCD or HFD for 6 weeks. I and J: Insulin tolerance tests (ITTs) and AUCs for ITT in WT and AdSod2 KO mice fed NCD or HFD for 21 weeks. n = 4–5 mice per group for A–D, n = 6 mice per group for E, and n = 8–17 mice per group for F–J. Scale bars = 20 μm in A and 400 μm in C. Data are mean ± SEM. *P < 0.05, **P < 0.005 vs. WT under the same feeding condition; #P < 0.05, ##P < 0.005 vs. NCD within the same genotype.

Tables

  • Figures
  • Table 1

    Serum metabolites, hormones, and lipids in WT and AdSod2 KO mice fed NCD or HFD

    NCDHFD
    WTAdSod2 KOWTAdSod2 KO
    Glucose (mg/dL)109.9 ± 8.199.3 ± 10.8146 ± 6.3##129.8 ± 5.9#
    T0 insulin (ng/mL)0.34 ± 0.060.3 ± 0.060.54 ± 0.060.21 ± 0.03**
    T30 insulin (ng/mL)0.48 ± 0.090.47 ± 0.10.47 ± 0.080.35 ± 0.05
    Leptin (ng/mL)5 ± 0.55.4 ± 0.814.6 ± 4.34.1 ± 0.9*
    Adiponectin (ng/mL)7,443.1 ± 505.17,242.1 ± 504.86,890 ± 413.87,183 ± 579.6
    FFA (mmol/L)0.46 ± 0.030.63 ± 0.070.46 ± 0.060.28 ± 0.03*
    Triglycerides (mg/dL)104.1 ± 8.192.2 ± 10.674.9 ± 16.863.3 ± 16.1
    Cholesterol (mg/dL)236.9 ± 27.7230.7 ± 10.8195.8 ± 31.6236.8 ± 19.1
    • Data are mean ± SEM. Serum metabolites, hormones, and lipids were measured after a 6-h fast. T0 insulin and T30 insulin correspond to insulin measured before glucose injection and 30 min after glucose injection, respectively, during GTTs. All other metabolites and hormones were determined by blood samples extracted before glucose injection before GTTs. n = 5 mice per genotype for NCD and n = 8 mice per genotype for HFD.

    • *P < 0.05 vs. WT mice under the same feeding condition.

    • **P < 0.005 vs. WT mice under the same feeding condition.

    • #P < 0.05 vs. NCD within the same genotype.

    • ##P < 0.005 vs. NCD within the same genotype.

PreviousNext
Back to top
Diabetes: 65 (9)

In this Issue

September 2016, 65(9)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Adipocyte-Specific Deletion of Manganese Superoxide Dismutase Protects From Diet-Induced Obesity Through Increased Mitochondrial Uncoupling and Biogenesis
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Adipocyte-Specific Deletion of Manganese Superoxide Dismutase Protects From Diet-Induced Obesity Through Increased Mitochondrial Uncoupling and Biogenesis
Yong Hwan Han, Márcio Buffolo, Karla Maria Pires, Shaobo Pei, Philipp E. Scherer, Sihem Boudina
Diabetes Sep 2016, 65 (9) 2639-2651; DOI: 10.2337/db16-0283

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Adipocyte-Specific Deletion of Manganese Superoxide Dismutase Protects From Diet-Induced Obesity Through Increased Mitochondrial Uncoupling and Biogenesis
Yong Hwan Han, Márcio Buffolo, Karla Maria Pires, Shaobo Pei, Philipp E. Scherer, Sihem Boudina
Diabetes Sep 2016, 65 (9) 2639-2651; DOI: 10.2337/db16-0283
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Research Design and Methods
    • Results
    • Discussion
    • Article Information
    • Footnotes
    • References
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Deficiency of Stat1 in CD11c+ Cells Alters Adipose Tissue Inflammation and Improves Metabolic Dysfunctions in Mice Fed a High-Fat Diet
  • Placental Insulin/IGF-1 Signaling, PGC-1α, and Inflammatory Pathways Are Associated With Metabolic Outcomes at 4–6 Years of Age: The ECHO Healthy Start Cohort
  • Defective FXR-SHP Regulation in Obesity Aberrantly Increases miR-802 Expression, Promoting Insulin Resistance and Fatty Liver
Show more Obesity Studies

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.